Search results

Slaughter and May advised Legal & General on the sale of Two Central Square, Cardiff Slaughter and May advised Legal & General on the sale of Two Central Square, Cardiff Slaughter and May is advising Bupa on its agreement to sell 22 of its UK care homes to Advinia Health Care Slaughter and May is advising Bupa on its agreement to sell 22 of its UK care homes to Advinia Health Care Slaughter and May advised Legal & General on the sale of 70 Gracechurch Street Slaughter and May advised Legal & General on the sale of 70 Gracechurch Street Slaughter and May advised Swiss Re Ltd on the sale of a minority stake in ReAssure Slaughter and May advised Swiss Re Ltd on the sale of a minority stake in ReAssure Slaughter and May is advising SEGRO plc in relation to a cash tender offer for certain of its existing Sterling bonds and the new issue of two Sterling bonds Slaughter and May is advising SEGRO plc in relation to a cash tender offer for certain of its existing Sterling bonds and the new issue of two Sterling bonds Slaughter and May is advising Peel Hunt LLP, as sponsor and broker to Hansteen Holdings plc Slaughter and May is advising Peel Hunt LLP, as sponsor and broker to Hansteen Holdings plc Slaughter and May advised Holmes Master Issuer on its issue of Notes Slaughter and May advised Holmes Master Issuer on its issue of Notes Slaughter and May advised Glenveagh Properties on its proposed initial public offering Slaughter and May is advising Glenveagh Properties PLC (“Glenveagh”) on its intention to proceed with an initial public offering of its ordinary shares. Slaughter and May advised Santander Consumer (UK) plc (SCUK) as originator, seller and servicer, and Santander UK plc as account bank, in relation to SCUK's Motor 2017-1 UK auto loan ABS transaction Slaughter and May advised Santander Consumer (UK) plc (SCUK) as originator, seller and servicer, and Santander UK plc as account bank, in relation to SCUK's Motor 2017-1 UK auto loan ABS transaction. Slaughter and May is advising Immunocore on a collaboration with the Bill & Melinda Gates Foundation Slaughter and May is advising Immunocore Limited, the world’s leading T cell receptor (“TCR”) company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases, on a collaboration with the Bill & Melinda Gates Foundation.